OnCore, from Advarra in Columbia (formerly known as Forte Research Systems) provides automated clinical research support featuring, billing and financial management, specimen management, reporting, effort tracking, and integration into other clinical systems.
N/A
Medrio
Score4.6 out of 10
N/A
Medrio offers solutions and support to pharmaceuticals, biotech, medical devices, and diagnostics, ensuring quality data capture and optimized workflows with CDMS/EDC, eCOA/ePRO, eConsent, and RTSM solutions.
Advarra is well suited for monitoring the progress of the clinical trials for a research organization. It's biggest advantage is the fact that the participants details and accrual monitoring shows the progress of the clinical trial. OnCore provides the capability of creating and using study calendars and especially monitoring and tracking participants visits. OnCore may be less appropriate to use in regards to grants and funds tracking.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
Medrio is very user friendly and even allows the user to print out the eCRFs to be used as source documents. This makes creating source documents very easy for the Research team and the information directly matches the EDC, which makes the monitoring process go much smoother. The process for withdrawing a subject can be a bit confusing, as the system only allows for a "screen-failure" designation and not an option for withdrawal, or is lost to follow-up.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
The system does not allow a separate designation for screen failures that were lost to follow-up or who were withdrawn by the PI.
When a subject is deemed a screen-failure, eCRFs are still expected to be filled out and it is unclear which ones unless otherwise directed by the in-house team.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
I have not had any technical issues with this product in the two years I've used it, which speaks for itself. I like how I am now able to use my email address to sign in instead of remembering yet another user name, this makes using this EDC a much more enjoyable experience.
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
A de minimis incentive was given to thank the reviewer for their time. The incentive was not used to bias or drive a particular response, nor was the incentive contingent on a positive endorsement. More Info
